Shokoofe Noori

907 total citations
43 papers, 726 citations indexed

About

Shokoofe Noori is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Shokoofe Noori has authored 43 papers receiving a total of 726 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 11 papers in Oncology and 11 papers in Immunology. Recurrent topics in Shokoofe Noori's work include Immunotherapy and Immune Responses (7 papers), Bioactive Compounds and Antitumor Agents (5 papers) and Sesquiterpenes and Asteraceae Studies (5 papers). Shokoofe Noori is often cited by papers focused on Immunotherapy and Immune Responses (7 papers), Bioactive Compounds and Antitumor Agents (5 papers) and Sesquiterpenes and Asteraceae Studies (5 papers). Shokoofe Noori collaborates with scholars based in Iran. Shokoofe Noori's co-authors include Zuhair Muhammad Hassan, Zuhair Mohammad Hassan, Mehrdad Kokabi, Afshin Zarghi, Mehdi Mahdavi, Mostafa Rezaei–Tavirani, Niloofar Deravi, Mohammad Taghikhani, Afshin Zarghi and Mitra Nourbakhsh and has published in prestigious journals such as SHILAP Revista de lepidopterología, Free Radical Biology and Medicine and Journal of Applied Polymer Science.

In The Last Decade

Shokoofe Noori

39 papers receiving 717 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shokoofe Noori Iran 15 261 114 110 82 78 43 726
Yanni Ma China 18 339 1.3× 112 1.0× 79 0.7× 62 0.8× 60 0.8× 50 761
Hemachand Tummala United States 19 341 1.3× 96 0.8× 154 1.4× 176 2.1× 70 0.9× 31 935
Lixia Pei China 15 311 1.2× 82 0.7× 70 0.6× 52 0.6× 46 0.6× 27 691
Mangala Hegde India 17 374 1.4× 78 0.7× 130 1.2× 63 0.8× 91 1.2× 51 967
Florina Bojin Romania 17 402 1.5× 154 1.4× 92 0.8× 80 1.0× 84 1.1× 47 913
Ziyu Jiang China 16 354 1.4× 69 0.6× 56 0.5× 77 0.9× 131 1.7× 37 829
An‐Cheng Huang Taiwan 15 444 1.7× 86 0.8× 53 0.5× 113 1.4× 100 1.3× 25 743
Dong Young Kang South Korea 19 521 2.0× 196 1.7× 138 1.3× 68 0.8× 141 1.8× 55 1.2k
Han Gon Choi South Korea 23 300 1.1× 84 0.7× 94 0.9× 187 2.3× 46 0.6× 38 1.0k
Singkome Tima Thailand 16 318 1.2× 90 0.8× 47 0.4× 92 1.1× 46 0.6× 62 695

Countries citing papers authored by Shokoofe Noori

Since Specialization
Citations

This map shows the geographic impact of Shokoofe Noori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shokoofe Noori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shokoofe Noori more than expected).

Fields of papers citing papers by Shokoofe Noori

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shokoofe Noori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shokoofe Noori. The network helps show where Shokoofe Noori may publish in the future.

Co-authorship network of co-authors of Shokoofe Noori

This figure shows the co-authorship network connecting the top 25 collaborators of Shokoofe Noori. A scholar is included among the top collaborators of Shokoofe Noori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shokoofe Noori. Shokoofe Noori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Nourbakhsh, Mitra, et al.. (2023). Attenuation of Inflammatory Responses in Breast and Ovarian Cancer Cells by a Novel Chalcone Derivative and Its Increased Potency by Curcumin. Mediators of Inflammation. 2023. 1–11. 5 indexed citations
3.
4.
Khoramjouy, Mona, et al.. (2023). Effects of Ziziphus Jujuba Extract Alone and Combined with Boswellia Serrata Extract on Monosodium Iodoacetate Model of Osteoarthritis in Mice. Iranian journal of pharmaceutical research. 21(1). e134338–e134338. 5 indexed citations
5.
Noori, Shokoofe, et al.. (2023). Co-treatment of Naringenin and Ketoprofen-RGD Suppresses Cell Proliferation via Calmodulin/PDE/cAMP/PKA Axis Pathway in Leukemia and Ovarian Cancer Cells. Iranian journal of pharmaceutical research. 22(1). e136131–e136131. 3 indexed citations
6.
Noori, Shokoofe, et al.. (2023). Hepatic Steatosis Alleviated by a Novel Metformin and Quercetin Combination Activating Autophagy Through the cAMP/AMPK/SIRT1 Pathway. Iranian journal of pharmaceutical research. 22(1). e136952–e136952. 8 indexed citations
7.
8.
Noori, Shokoofe, et al.. (2023). A novel combination of metformin and resveratrol alleviates hepatic steatosis by activating autophagy through the cAMP/AMPK/SIRT1 signaling pathway. Naunyn-Schmiedeberg s Archives of Pharmacology. 396(11). 3135–3148. 11 indexed citations
9.
Noori, Shokoofe, et al.. (2022). Naringenin and cryptotanshinone shift the immune response towards Th1 and modulate T regulatory cells via JAK2/STAT3 pathway in breast cancer. BMC Complementary Medicine and Therapies. 22(1). 145–145. 23 indexed citations
10.
Mokarram, Pooneh, Saeed Karima, Ramazan Rezaei, et al.. (2022). Resveratrol promotes liver cell survival in mice liver-induced ischemia-reperfusion through unfolded protein response: a possible approach in liver transplantation. BMC Pharmacology and Toxicology. 23(1). 74–74. 11 indexed citations
11.
Noori, Shokoofe, et al.. (2020). Naringenin Enhances the Anti-Cancer Effect of Cyclophosphamide against MDA-MB-231 Breast Cancer Cells Via Targeting the STAT3 Signaling Pathway.. Iranian journal of pharmaceutical research. 19(3). 122–133. 48 indexed citations
12.
Noori, Shokoofe, et al.. (2020). A Ferrocene Derivative Reduces Cisplatin Resistance in Breast Cancer Cells through Suppression of MDR-1 Expression and Modulation of JAK2/STAT3 Signaling Pathway. Anti-Cancer Agents in Medicinal Chemistry. 20(18). 2285–2292. 7 indexed citations
13.
Noori, Shokoofe, et al.. (2020). Anti-Breast Cancer Activities of Ketoprofen-RGD Conjugate by Targeting Breast Cancer Stem-Like Cells and Parental Cells. Anti-Cancer Agents in Medicinal Chemistry. 21(8). 1027–1036. 10 indexed citations
14.
Azimi, Maryam, Zuhair Muhammad Hassan, Ahmad Zavaran Hosseini, et al.. (2013). Study of immunomodulatory effects of arteether administrated intratumorally.. SHILAP Revista de lepidopterología. 12(1). 57–62. 3 indexed citations
15.
Noori, Shokoofe, et al.. (2013). Antitumor and immunomodulatory effects of salvigenin on tumor bearing mice. Cellular Immunology. 286(1-2). 16–21. 27 indexed citations
16.
Azimi, Maryam, Zuhair Mohammad Hassan, Ahmad Zavaran Hosseini, et al.. (2013). Arteether exerts antitumor activity and reduces CD4+CD25+FOXP3+ T-reg cells in vivo.. PubMed. 10(3). 139–49. 12 indexed citations
17.
Noori, Shokoofe & Zuhair Muhammad Hassan. (2011). Dihydroartemisinin shift the immune response towards Th1, inhibit the tumor growth in vitro and in vivo. Cellular Immunology. 271(1). 67–72. 53 indexed citations
18.
Noori, Shokoofe, Mohammad Taghikhani, Zuhair Muhammad Hassan, Abdolamir Allameh, & Ali Mostafaei. (2010). Tehranolide molecule modulates the immune response, reduce regulatory T cell and inhibits tumor growth in vivo. Molecular Immunology. 47(7-8). 1579–1584. 26 indexed citations
19.
Ebtekar, Massoumeh, et al.. (2010). A comparison of low-dose cyclophosphamide treatment with artemisinin treatment in reducing the number of regulatory T cells in murine breast cancer model. International Immunopharmacology. 10(9). 1055–1061. 44 indexed citations
20.
Noori, Shokoofe, Mohammad Taghikhani, Zuhair Muhammad Hassan, Abdolamir Allameh, & Ali Mostafaei. (2009). Tehranolide Could Shift the Immune Response Towards Th1 and Modulate the Intra-tumor Infiltrated T Regulatory Cells. PubMed. 6(4). 216–24. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yanni Ma Breakdown of academic impact, for papers by Hemachand Tummala Breakdown of academic impact, for papers by Lixia Pei Breakdown of academic impact, for papers by Mangala Hegde Breakdown of academic impact, for papers by Florina Bojin Breakdown of academic impact, for papers by Ziyu Jiang Breakdown of academic impact, for papers by An‐Cheng Huang Breakdown of academic impact, for papers by Dong Young Kang Breakdown of academic impact, for papers by Han Gon Choi Breakdown of academic impact, for papers by Singkome Tima
Rankless by CCL
2026